PSYCHEMEDICS CORPORATION - COMMON STOCK
2.3300
25-November-24 11:07:49
15 minutes delayed
Stocks
-0.0050
-0.21%
Today's range
2.3250 - 2.3400
ISIN
N/A
Source
NASDAQ
-
18 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
12 Nov 2024 16:05:23 By Nasdaq GlobeNewswire
-
26 Sep 2024 09:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Launches New Ketamine Hair Testing Service
29 Aug 2024 09:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
13 Aug 2024 16:05:16 By Nasdaq GlobeNewswire
-
12 Aug 2024 16:12:58 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK
08 Aug 2024 15:52:54 By NetDania Notify
-
NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK
05 Aug 2024 13:40:55 By NetDania Notify
-
NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK
02 Aug 2024 13:42:15 By NetDania Notify
-
NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK
26 Jul 2024 15:35:48 By NetDania Notify
-
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
21 Jun 2024 10:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Reports First Quarter 2024 Financial Results
14 May 2024 16:55:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Reports 2023 Financial Results
28 Mar 2024 08:20:00 By Nasdaq GlobeNewswire
-
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
21 Mar 2024 09:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
02 Jan 2024 11:27:42 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
27 Nov 2023 09:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Reports Third Quarter 2023 Financial Results
09 Nov 2023 17:00:59 By Nasdaq GlobeNewswire
-
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
27 Oct 2023 11:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
21 Sep 2023 17:00:00 By Nasdaq GlobeNewswire
-
Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Aug 2023 14:00:40 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >